Search results
Looking For Passive Income? Here Are 5 Ultra-High-Yield Dividend Stocks to Buy and Hold For a Decade
Motley Fool via Yahoo Finance· 3 hours agoSome of the best, proven sources of dividend income involve real estate investment trusts, master...
Tom Woods and Brent Orrell debate COVID lockdowns
Reason.com· 2 days agoImportant Update from The Soho Forum: "[We regret] to inform you of a significant change to tonight's debate between Brent Orrell and Tom Woods....
Online payments help SNAP customers put more farm-grown food on their tables. Here's how
The Arizona Republic· 8 hours agoGrocery delivery has been an option for many Arizonans for several years — except if they count on...
UPDATED: Boca Raton art museum’s ‘Creature Features’ extended, but time’s running out to catch...
Sun-Sentinel· 5 days agoUPDATED April 22, 2024: Don’t call this fake news, but Tony Oursler’s “Creature Features” gallery, a...
14 recent scientific breakthroughs
The Week via Yahoo News· 4 days agoPetri dish illustration. Editor's note: This article was updated April 18, 2024. Scientists in many fields received little recognition for the last...
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
Motley Fool via Yahoo Finance· 1 day ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance...
National COVID-19 guidelines vary widely, often promote ineffective treatments
Center for Infectious Disease Research and Policy· 5 days agoThe authors considered the gold standard for clinical guidelines to be the World Health...
2 Beaten-Down Dividend Stocks to Buy and Hold Forever
Motley Fool via Yahoo Finance· 9 hours ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance...
Former Ohio governor candidate leaving Biden administration
WCMH Columbus· 9 hours agoNBC4’s Colleen Marshall interviews Richard Cordray in 2022 in the video player above. COLUMBUS, Ohio...
UPDATE 2-Roche eyes return to growth after Q1 hit by forex, loss of COVID sales
Reuters via Yahoo Finance· 5 days agoRoche confirmed ambitions to return to sales growth this year on a continued boost from eye drug Vabysmo, after first-quarter sales slipped by 6% on the loss on COVID-19-related ...